Notably, we also found that MCT1 and 4 are co-overexpressed in the large majority of primary leukemic blasts analyzed, as compared to normal CD34+ HPCs, and in all FAB AML subtypes. This evidence concerns the gene SLC16A1 and acute myeloid leukemia.